AI assistant
SURMODICS INC — Director's Dealing 2021
Feb 18, 2021
32845_dirs_2021-02-18_394af978-8a61-4677-9333-f0712f296a39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-02-16
Reporting Person: Stich Joseph J. (SVP, HR and GM, IVD)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-16 | Common Stock | S | 2016 | $51.4993 | Disposed | 48546 | Direct |
| 2021-02-16 | Common Stock | S | 484 | $52.5082 | Disposed | 48062 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2020.
F2: Reflects the weighted average price of 2,016 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 16, 2021 with sale prices ranging from $51.00 to $51.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 484 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 16, 2021 with sale prices ranging from $52.355 to $53.23 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.